Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a tumour that exhibits both
hepatocytic and biliary differentiation. Classical risk factors for hepatocellular carcinoma …

Combined hepatocellular cholangiocarcinoma (CC) is a rare and aggressive primary
hepatic malignancy with significant histological and biological heterogeneity. It presents with …

Abstract An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus
meeting of expert panellists met on 15 January 2014 to review current evidence on the …

Background Combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) is an
uncommon subtype of primary liver cancer that has rarely been reported in large-scale …

Abstract Background: Hepatocholangiocarcinoma (HCC-CC) is a rare liver malignancy that
contains features of both hepatocellular carcinoma (HCC) and mass-forming …

Liver transplantation for cholangiocarcinoma has been an absolute contraindication
worldwide due to poor results. However, in recent years and thanks to improvements of …

Combined hepatocellular‐cholangiocarcinoma (cHCC‐CC) is a rare primary liver cancer.
Our aims were to analyze the demographic, clinical, and pathological characteristics of …

Background Combined hepatocellular-cholangiocarcinoma (CHC) is a rare subtype of
primary hepatic malignancies, with variably reported incidence between 0.4%–14.2% of …

Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare type of primary liver
malignancy. Among the risk factors, hepatitis B and hepatitis C virus infections, cirrhosis, and …

Combined hepatocellular-cholangiocarcinoma (CHC) is a rare tumor with poor prognosis,
with incidence ranging from 1.0%-4.7% of all primary hepatic tumors. This entity will be soon …